Fellowship

2015 Leverhulme Trust Emeritus Fellowships for study in UK.

Google+ Pinterest LinkedIn Tumblr

Application Deadline:5 February 2015

The Leverhulme Trust Board, through its Research Awards Advisory Committee, is offering approximately 35 Emeritus Fellowships. The primary intention of the scheme is to support the facilitation, integration or completion of the applicant’s own personal research output, rather than general further support for his or her research group or research assistants.

The Leverhulme Trust Emeritus Fellowships Providing research expenses of up to £22,000 over up to two years to enable senior researchers who have retired from an academic post to complete a research project and prepare the results for publication.

Value

The maximum value of a Fellowship is £22,000.

Eligibility

Applicants must:

  • be resident in the UK at the time of application;
  • hold or have held a teaching and/or research post at a university or comparable institution in the UK at the point of retirement;
  • have retired by the time of taking up the Fellowship and no longer have a normal contract of employment.

Applications will be considered in all subject areas with the exception of research that is of direct relevance to clinicians, medical professionals and/or the pharmaceutical industry.

Eligible costs

  • Travel and subsistence costs for periods away from home
  • The employment of a research, clerical or secretarial assistant to support (rather than conduct) the work of the applicant
  • Photocopies
  • Photographic expenses
  • Office or laboratory consumables.

There is no provision for a personal maintenance allowance or remuneration for the applicant under this scheme. Please ensure that applications do not include any ineligible costs.

Duration

Fellowships are tenable for between 3 and 24 months, and the current round of awards must commence between 1 August 2015 and 1 July 2016.

For More Information:

Visit the Official Webpage of the Leverhulme Trust Emeritus Fellowships for study in UK.

Comments are closed.